JSGCF yields 5.07% · PFE yields 6.13%● Live data
📍 JSGCF pulled ahead of the other in Year 1
Combined, JSGCF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of JSGCF + PFE for your $10,000?
LIXIL Corporation, through its subsidiaries, manufactures and sells building materials and housing equipment worldwide. It operates through LIXIL Water Technology (LWT), LIXIL Housing Technology (LHT), LIXIL Building Technology (LBT), and Housing & Services Business (H&S) segments. The LWT segment offers sanitary ware, shower toilets, water faucets, washstands, bathtubs, prefabricated bathrooms, smart products, showerheads, washstand fixtures, washstand cabinet units, kitchen systems, etc.; and tiles for houses and buildings, and internal decorative tiles, etc. This segment offers its products under the INAX, GROHE, American Standard, COBRA, DXV, Jaxson, RICHELLE, and SPAGE brands. The LHT segment provides housing window sashes, entrance doors, various types of shutters, gates, carports, banisters, high railings, etc.; window frames, wooden furnishing materials, interior decorative materials, etc.; sidings, roofing materials, etc.; and solar power systems, etc. This segment offers its products under the Tostem, Exsior, Interio, Super Wall, Nodea, and Asahi Tostem brands. The LBT segment offers curtain walls, building window sashes, store facades, etc. The H&S segment engages in the development of homebuilding franchise chains, construction on order, etc.; and provides services for land, buildings, real estate management, real estate franchises development support, etc., as well as housing loans. This segment offers its products under the Lixil, Eyeful Home, Face Home, ERA, and GL HOME brands. The company was formerly known as LIXIL Group Corporation and changed its name to LIXIL Corporation in December 2020. LIXIL Corporation was founded in 1875 and is headquartered in Tokyo, Japan.
Full JSGCF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.